3D PREDICT GLIOMA

Welcome to the Brand page for “3D PREDICT GLIOMA”, which is offered here for Scientific instruments and apparatus for ex vivo three-dimensional cell culture; scientific instruments and apparatus for ex vivo microtumor modeling; kits comprising scientific instruments, instruments for performing clinical or research assays of anti-cancer therapies;assay kits comprising clinical medical reagents for culturing cells for clinical medical use;three dimensional predict glioma;assays for clinical laboratory or research purposes, for testing anti-cancer therapies, other than for medical or veterinary use; assays for use in anti-cancer therapy research; assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; assay kits comprising cell culture reagents and assays for culturing cells for clinical laboratory or research use;medical clinical testing services for diagnostic or treatgment purposes, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; medical services in the nature of personalized medicine services, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies;medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies;medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; pharmaceutical research services, preclinical assessment of pharmaceutical drugs; scientific and technological services, research in the field of anti-cancer therapies using ex vivo assays; medical testing services, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, nor for diagnostic or treatment purposes; providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; laboratory research in the field of oncology;.

Its status is currently believed to be active. Its class is unavailable. “3D PREDICT GLIOMA” is believed to be currently owned by “KIYATEC Inc.”